Revenue
2022
2023
2024
2025
Nervgen Pharma Corp. (NGEN)
Price$2.33Cached quote
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Research & development | $13.9M | $15.8M | $8.0M | $16.6M |
| Operating expenses | $25.1M | $25.2M | $17.8M | $23.0M |
| Operating income | −$25.1M | −$25.2M | −$17.8M | −$23.0M |
| EBITDA | −$25.0M | −$25.1M | −$17.6M | −$20.1M |
| Net income | −$44.1M | −$24.3M | −$22.4M | −$20.7M |
| Basic EPSper basic share | -CA$0.61 | -CA$0.36 | -CA$0.38 | -CA$0.39 |
| Diluted EPSper diluted share | -CA$0.61 | -CA$0.36 | -CA$0.38 | -CA$0.39 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Empery Asset Management, LP | 4M |
Rock Springs Capital Management LP | 1.21M |
DAFNA Capital Management LLC | 1.05M |
Ghisallo Capital Management LLC | 1M |
ARMISTICE CAPITAL, LLC | 678K |
LMR Partners LLP | 600K |
MARSHALL WACE, LLP | 435.96K |
UBS Group AG | 379.73K |
Stonepine Capital Management, LLC | 271.68K |
JANE STREET GROUP, LLC | 270.75K |
Woodline Partners LP | 250.5K |
PFG Investments, LLC | 217.5K |
BANK OF AMERICA CORP /DE/ | 186.2K |
ROYAL BANK OF CANADA | 176.08K |
Quadrature Capital Ltd | 134.52K |
BANK OF MONTREAL /CAN/ | 78.39K |
Integrated Wealth Concepts LLC | 74.22K |
CAPTRUST FINANCIAL ADVISORS | 64.42K |
GEODE CAPITAL MANAGEMENT, LLC | 58.04K |
OSAIC HOLDINGS, INC. | 51.09K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data